Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINISK TANDTEKNIKER ELKE NEBEL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   1.6% 7.0% 5.9% 4.4% 6.4% 29.2% 17.5% 17.3%   Credit score (0-100)   76 36 39 46 36 1 9 9   Credit rating   A BBB BBB BBB BBB C B BB   Credit limit (kDKK)   3.2 0.0 0.0 0.0 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 2,881 2,787 0 0 0 0 0   Gross profit   1,822 1,985 1,898 1,734 763 397 0.0 0.0   EBITDA   316 -48.8 165 59.5 -191 -242 0.0 0.0   EBIT   245 -146 61.0 -17.1 -267 -274 0.0 0.0   Pre-tax profit (PTP)   245.0 -146.8 58.7 -23.3 -269.8 -279.1 0.0 0.0   Net earnings   188.8 -109.8 44.0 -18.8 -251.6 -285.5 0.0 0.0   Pre-tax profit without non-rec. items   245 -147 58.7 -23.3 -270 -279 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   316 298 235 159 82.1 62.6 0.0 0.0   Shareholders equity total   759 536 465 446 137 -149 -190 -190   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 20.3 190 190   Balance sheet total (assets)   1,106 977 1,116 865 361 197 0.0 0.0   Net Debt   -663 -486 -724 -468 -101 20.3 190 190     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 2,881 2,787 0 0 0 0 0   Net sales growth   0.0% 0.0% -3.3% -100.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,822 1,985 1,898 1,734 763 397 0.0 0.0   Gross profit growth   -5.9% 9.0% -4.4% -8.7% -56.0% -48.0% -100.0% 0.0%   Employees   0 0 0 2 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,106 977 1,116 865 361 197 0 0   Balance sheet change%   -1.8% -11.6% 14.2% -22.5% -58.3% -45.3% -100.0% 0.0%   Added value   315.9 -48.8 165.2 59.5 -190.8 -242.0 0.0 0.0   Added value %   0.0% -1.7% 5.9% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   152 -115 -167 -153 -153 -51 -63 0   Net sales trend   0.0 0.0 -1.0 -2.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% -1.7% 5.9% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% -5.1% 2.2% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.5% -7.4% 3.2% -1.0% -35.1% -69.0% 0.0% 0.0%   Net Earnings %   0.0% -3.8% 1.6% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% -0.4% 5.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% -5.1% 2.1% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   22.0% -14.1% 5.8% -1.7% -43.6% -77.4% 0.0% 0.0%   ROI %   31.7% -22.6% 12.2% -3.8% -91.8% -347.9% 0.0% 0.0%   ROE %   24.5% -17.0% 8.8% -4.1% -86.3% -170.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   68.6% 54.8% 41.6% 51.5% 38.0% -42.9% -100.0% -100.0%   Relative indebtedness %   0.0% 15.3% 23.4% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% -1.5% -2.6% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -209.9% 996.1% -438.5% -786.9% 53.0% -8.4% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% -13.6% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 54.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.1 1.3 1.2 1.5 1.0 0.2 0.0 0.0   Current Ratio   2.2 1.4 1.3 1.6 1.1 0.3 0.0 0.0   Cash and cash equivalent   663.0 486.2 724.4 467.9 101.1 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 8.8 7.3 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 33.8 18.4 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 21.4% 29.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   416.5 173.8 180.2 257.9 25.7 -240.3 -94.8 -94.8   Net working capital %   0.0% 6.0% 6.5% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 30 -191 -242 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 30 -191 -242 0 0   EBIT / employee   0 0 0 -9 -267 -274 0 0   Net earnings / employee   0 0 0 -9 -252 -286 0 0